Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Vulvar Cancer

New Issue Alert: CURE Women's Cancers

Katie Kosko and Brielle Benyon

We've got a sneak peek at what’s inside CURE®'s Women’s Cancers issue.

Patients With Gynecologic Cancers Want to Discuss Sexual Health

Katie Kosko

Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.

FDA Approves Age Expansion of HPV Vaccine

Brielle Urciuoli

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

FDA Grants Priority Review to GARDASIL 9 for Expanded Age Indication

Kristie L. Kahl

The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.

HPV Status Linked to Overall and Disease-Free Survival in Vulvar Cancer

Katie Kosko

Women with vulvar cancer who test positive for human papillomavirus (HPV) may have improved survival compared with HPV-negative patients, according to the results of a new study.

Despite Benefits, HPV Vaccination Rates Remain Too Low

Jason Harris

Despite impressive efficacy for the human papillomavirus (HPV) vaccine reducing the prevalence of high-risk oral HPV infections by 88 percent, many young adults still are not getting the vaccine – sparking concern in the health community.

NCCN Introduces Updated Vulvar Cancer Guideline

Wayne Kuznar

Treatment changes for the rare illness include less invasive surgery.

HPV Vaccination in Boys Found Cost-Effective in Preventing Oropharyngeal Cancer

Christina Izzo

A new study has shown that vaccinating adolescent boys may be cost-effective for preventing oropharyngeal cancer, a disease that's projected to become the most common HPV-related cancer by 2020.

Study Highlights Geographical Differences in Cervical Cancer Incidence

Beth Fand Incollingo

States with the highest incidence of, and mortality from, cervical cancer also have the lowest uptake of the human papillomavirus (HPV) vaccine by adolescent girls, researchers found in a recent study.

The Thing About Risk

There are some things known to increase the risk of gynecologic cancers. Bottom line, being a woman puts you at risk.

Vulvar Cancer

Sign In